![Antimicrobial Resistance [AMR] in Hausa](https://healthtoday.com.ng/wp-content/uploads/2024/02/antimicrobial-resistance-AMR--360x180.jpeg)
Nigeria faced a severe Neisseria meningitis outbreak, prompting global concern. Amidst this crisis, an intriguing claim emerged: Nigeria became the first country to introduce the Men5CV vaccine.
There have being a vaccination campaign launched by Nigeria in March 2024, targeting over one million individuals aged 1 to 29. The World Health Organization (WHO) unequivocally confirmed Nigeria’s pioneering status, praising the nation’s proactive approach in combatting meningitis.
The rollout of the Men5CV vaccine represents a pivotal moment in the fight against meningitis. Nigeria, located within the African Meningitis Belt, has historically grappled with meningitis outbreaks. This historic initiative not only aligns with WHO’s ambitious goal to eradicate meningitis by 2030 but also underscores Nigeria’s commitment to public health.
Nigeria is the first country to implement the Men5CV vaccine. This milestone marks a significant leap forward in protecting lives and curbing the spread of meningitis, not only in Nigeria but also across the African Meningitis Belt.
